Forager’s Chief Investment Officer, @ForagerSteve discusses the Paragon Care investment thesis, the recent acquisition of CH2, and the potential consequences for the healthcare distribution sector generally. Read the @LivewireMarkets article for the full story: https://bit.ly/4bh7cjK
Forager Funds Management’s Post
More Relevant Posts
-
As shown in the figures below, recent healthcare acquisitions continued to be dominated by three sectors: Physician Medical Groups, Other Services, and eHealth. Despite declines in transaction activity in Q1, the Physician Medical Group sector remained the most active sector in terms of total transactions as a result of continued interest from health system and private equity buyers alike, accounting for 25.2% of total deal volume. Continue reading: https://ankura.co/3yNasF8 #HealthcareTrends #MergersAndAcquisitions #HealthcareIndustry #Q12024Insights #AnkuraInsights #HealthcareTransactions #MarketAnalysis #IndustryInsights #InvestmentTrends #RegulatoryImpact
Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q1 2024]
angle.ankura.com
To view or add a comment, sign in
-
CEO, Synergetics | Transformational Leader in the Consulting & Private Equity Space | Passionate about Business Solutions & Innovation
Looking forward, PE sponsors must instill higher confidence in identifying value-creation opportunities at an earlier stage. This is the most straightforward way to justify larger capital commitments. Moreover, sponsors ought to broaden their perspective beyond due diligence, focusing on a more holistic range of operational, technological, and governmental factors. We need strategic fund strategies, paired with ethical and meaningful practices. #PrivateEquity #Healthcare #Strategy #ValueCreation
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
To view or add a comment, sign in
-
In a striking counter to the market's downtrend, #CapitolHealth Ltd's shares leapt by 20% post a takeover bid from Integral Diagnostics Ltd, making headlines in the diagnostic imaging services sector. 📈🏥 This bold move saw #CapitolHealth's shares climb to 29.5 cents, indicating a seismic shift in the market, propelled by a bid that values the company's shares at a 33% premium to the prior close. 💡 Key insights: - A scheme of arrangement is in place for 100% acquisition. - Shareholders could see significant value addition thanks to the enhanced growth and capabilities of the combined entities. The endorsement of the takeover by Capitol Health's management underscores the potential for nurturing market relevance through strategic partnerships.✨ This isn't just about a rise in shares—it's about setting a new competitive standard in Australia's healthcare sector and perhaps, a new chapter in quality service provision. Shareholders, brace for a transformative journey ahead. For more insights into what this means for the #HealthcareIndustry, read on: https://lnkd.in/g3j8SDpJ #MergersAndAcquisitions #HealthcareSector #MarketWatch #TakeoverBid #StrategicAlliances
Capitol Health Shares Surge on Takeover Acceptance
https://bullstreet.com.au
To view or add a comment, sign in
-
This is a great insight piece from Mergermarket on 2024 market trends in the European M&A #healthcare market. Activity in this area looks to be increasing compared to the last 12 months. #Goodwin
Goodwin's Sophie McGrath and Arvin Abraham recently shared their predictions for trends in European #Healthcare M&A with Christel Thunell of Mergermarket. In the life sciences space, both private and public ones, are now running low on funds and will have to come back to market and raise further capital in 2024. As valuations are now lower, this will drive two trends: down rounds and opportunistic M&A - Sophie McGrath. Increased pressure on businesses that need funding or need to exit will boost M&A levels in 2024, especially considering the amount of capital available to PE funds, which are keen to invest into healthcare - Arvin Abraham. Read the full analysis: #mergersandacquisitions #goodwinlaw
European healthcare M&A to stay strong in 2024 as valuation gap narrows - Trendspotter - ION Analytics
https://ionanalytics.com
To view or add a comment, sign in
-
The 2023 Results are out! And they are looking good 😎 Increase in revenue ✅ Rise in operating profits ✅ Acquisitions and Growth ✅ Early delivery on our IPO targets ✅ For more details, have a look in this article from RTE with our Group CEO Ger Rabbette Keep an eye on our website where the full results will be shared shortly 📈 #rte #uniphar #unipharjobs #revenue #2023results
Uniphar's revenues for 2023 rise by 23%
rte.ie
To view or add a comment, sign in
-
Take-private transactions 🔏 💰 👩⚕️ 🚑 Thoma Bravo has completed the $1.8bn take private of NextGen Healthcare, an Atlanta-based provider of software used in handling electronic medical records. The deal was announced in September. NextGen Healthcare serves more than 100,000 ambulatory healthcare providers who care for more than 65 million patients in the US. Earlier in the week, Francisco Partners and TPG completed the previously announced take-private deal of New Relic, a provider of tools for developing software, for $6.5 billion. New Relic stockholders approved the deal on November 2. OTHER DEALS: 🤝 💼 Health tech firm Virgin Pulse and New Mountain Capital-backed HeathComp complete merger Caisse de dépôt et placement du Québec (CDPQ) backs AVENIR GLOBAL's growth with minority investment TJC (The Jordan Company) to sell CPI's electronic device business to TransDigm Group Inc. Fort Point Capital-backed Jones Lake Management buys pond management services provider Ponds Rx Sterling Partners exits music education franchise School of Rock #privateequity #privateequityfirms
To view or add a comment, sign in
-
Read the MedTech Strategies LLC article below about our most recent event on healthcare's current (and future) financing trends. Don't miss Gabriele Brambilla's suggestions for the new year: 1) Watch for microeconomic trends to see what might affect your pathway. 2) Be creative and use different channels to develop relationships and adjust your approach. 3) Focus on clinical evidence and patient impact that might come through a clinical pathway other than 510k. 4) And of course, never give up!
Are you ready for a turnaround in MedTech Funding? I think we all are... MedTech Strategies LLC, N.E. Healthcare Executive Network, Cicada Gabriele Brambilla, Sean J. Cheng, Federico GM Mennella, CFA, Joshua Phillips, Alan Lucas
Is the wait over for MedTech Investment and M&A? Not yet...
medtechstrategiesllc.com
To view or add a comment, sign in
-
Macroeconomic challenges have exacted a toll on healthcare buyouts, but green shoots in deal activity reflect the industry’s strong fundamentals. Explore the year in review and discover the outlook for the year ahead in our 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
To view or add a comment, sign in
-
Macroeconomic challenges have exacted a toll on healthcare buyouts, but green shoots in deal activity reflect the industry’s strong fundamentals. Explore the year in review and discover the outlook for the year ahead in our 2024 Global Healthcare Private Equity Report.
Healthcare Private Equity Market 2023: Year in Review and Outlook
bain.com
To view or add a comment, sign in